As FDA delays Novavax' COVID vaccine approval, patients fight back
Go back to As FDA delays Novavax' COVID vaccine approval, patients fight back| (NASDAQ: BNTX) | Delayed: 98.48 +0.02 (0.02%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $98.46 | 52 Week High | $ | |||
| Open | $97.62 | 52 Week Low | $ | |||
| Day High | $99.59 | P/E | N/A | |||
| Day Low | $97.05 | EPS | $ | |||
| Volume | 215,982 | |||||
